Literature DB >> 19862739

Subcomplexes of mitochondrial complex V reveal mutations in mitochondrial DNA.

Joél Smet1, Sara Seneca, Boel De Paepe, Ann Meulemans, Helene Verhelst, Jules Leroy, Linda De Meirleir, Willy Lissens, Rudy Van Coster.   

Abstract

Complex V, site of the final step in oxidative phosphorylation, uses the proton gradient across the inner mitochondrial membrane for the production of ATP. It is a multi-subunit complex composed of a catalytic domain (F(1)) and a membrane domain (F(0)) linked by two stalks. Subcomplexes of complex V containing the F(1) domain have previously been reported in small series of patients. We report the results in tissue samples and/or cultured skin fibroblasts studied by blue native PAGE followed by activity staining in the gel. Catalytically active subcomplexes of complex V were detected in 66 tissues originating from 53 patients. In 29 of the latter (55%), a mitochondrial DNA (mtDNA) defect was identified. Twelve patients had a pathogenic point mutation in a mitochondrial tRNA, one a large mtDNA deletion, 12 showed mtDNA depletion and four had a mutation in the MT-ATP6 gene. We conclude that the presence of subcomplexes of complex V is a valuable indicator in the detection of mtDNA defects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19862739     DOI: 10.1002/elps.200900213

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  11 in total

1.  Potentially diagnostic electron paramagnetic resonance spectra elucidate the underlying mechanism of mitochondrial dysfunction in the deoxyguanosine kinase deficient rat model of a genetic mitochondrial DNA depletion syndrome.

Authors:  Brian Bennett; Daniel Helbling; Hui Meng; Jason Jarzembowski; Aron M Geurts; Marisa W Friederich; Johan L K Van Hove; Michael W Lawlor; David P Dimmock
Journal:  Free Radic Biol Med       Date:  2016-01-08       Impact factor: 7.376

Review 2.  Mitochondrial genetic diseases.

Authors:  Marni J Falk; Neal Sondheimer
Journal:  Curr Opin Pediatr       Date:  2010-12       Impact factor: 2.856

3.  Extremely high mutation load of the mitochondrial 8993 T>G mutation in a newborn: implications for prognosis and family planning decisions.

Authors:  Claudine De Praeter; Arnaud Vanlander; Piet Vanhaesebrouck; Joél Smet; Sara Seneca; Petra De Sutter; Rudy Van Coster
Journal:  Eur J Pediatr       Date:  2014-07-10       Impact factor: 3.183

4.  Activation of a cryptic splice site in the mitochondrial elongation factor GFM1 causes combined OXPHOS deficiency.

Authors:  Mariella T Simon; Bobby G Ng; Marisa W Friederich; Raymond Y Wang; Monica Boyer; Martin Kircher; Renata Collard; Kati J Buckingham; Richard Chang; Jay Shendure; Deborah A Nickerson; Michael J Bamshad; Johan L K Van Hove; Hudson H Freeze; Jose E Abdenur
Journal:  Mitochondrion       Date:  2017-02-12       Impact factor: 4.160

5.  The mitochondrial DNA variant m.9032T > C in MT-ATP6 encoding p.(Leu169Pro) causes a complex mitochondrial neurological syndrome.

Authors:  Kaz M Knight; Emily Shelkowitz; Austin A Larson; David M Mirsky; Yue Wang; Ting Chen; Lee-Jun Wong; Marisa W Friederich; Johan L K Van Hove
Journal:  Mitochondrion       Date:  2020-09-12       Impact factor: 4.160

6.  Mitochondrial energy failure in HSD10 disease is due to defective mtDNA transcript processing.

Authors:  Kathryn C Chatfield; Curtis R Coughlin; Marisa W Friederich; Renata C Gallagher; Jay R Hesselberth; Mark A Lovell; Rob Ofman; Michael A Swanson; Janet A Thomas; Ronald J A Wanders; Eric P Wartchow; Johan L K Van Hove
Journal:  Mitochondrion       Date:  2015-01-06       Impact factor: 4.160

7.  Aberrant synthesis of ATP synthase resulting from a novel deletion in mitochondrial DNA in an African patient with progressive external ophthalmoplegia.

Authors:  Francois H van der Westhuizen; Joél Smet; Oksana Levanets; Madelein Meissner-Roloff; Roan Louw; Rudy Van Coster; Izelle Smuts
Journal:  J Inherit Metab Dis       Date:  2010-01-16       Impact factor: 4.982

Review 8.  Evaluation of the child with suspected mitochondrial liver disease.

Authors:  Jean P Molleston; Ronald J Sokol; Wikrom Karnsakul; Alexander Miethke; Simon Horslen; John C Magee; René Romero; Robert H Squires; Johan L K Van Hove
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-09       Impact factor: 2.839

9.  Severe hepatopathy and neurological deterioration after start of valproate treatment in a 6-year-old child with mitochondrial tryptophanyl-tRNA synthetase deficiency.

Authors:  Elise Vantroys; Joél Smet; Arnaud V Vanlander; Sarah Vergult; Ruth De Bruyne; Frank Roels; Hedwig Stepman; Herbert Roeyers; Björn Menten; Rudy Van Coster
Journal:  Orphanet J Rare Dis       Date:  2018-05-21       Impact factor: 4.123

10.  Hybrid gel electrophoresis using skin fibroblasts to aid in diagnosing mitochondrial disease.

Authors:  Christopher Newell; Aneal Khan; David Sinasac; John Shoffner; Marisa W Friederich; Johan L K Van Hove; Stacey Hume; Jane Shearer; Iveta Sosova
Journal:  Neurol Genet       Date:  2019-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.